Home/Filings/4/0001127602-23-012226
4//SEC Filing

GUERTIN SHAWN M 4

Accession 0001127602-23-012226

CIK 0000064803other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:28 PM ET

Size

9.0 KB

Accession

0001127602-23-012226

Insider Transaction Report

Form 4
Period: 2023-04-01
GUERTIN SHAWN M
EVP & Chief Financial Officer
Transactions
  • Award

    Stock Option

    2023-04-01$74.31/sh+148,456$11,031,765148,456 total
    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (148,456 underlying)
Holdings
  • Common Stock

    9,260
  • Stock Option

    Exercise: $1.00From: 2022-05-28Exp: 2031-05-28Common Stock (97,562 underlying)
    97,562
  • Common Stock (Restricted)

    34,706
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (103,950 underlying)
    103,950
Footnotes (2)
  • [F1]Option became exercisable in four equal installments, commencing 4/1/2023.
  • [F2]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001231553

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:28 PM ET
Size
9.0 KB